{
  "nctId": "NCT04587050",
  "briefTitle": "Screening for HPV and Cervical Cancer in Young Women With Perinatally Acquired HIV",
  "officialTitle": "Screening for Human Papillomavirus and Cervical Cancer in Young Women With Perinatally Acquired HIV",
  "protocolDocument": {
    "nctId": "NCT04587050",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2019-11-01",
    "uploadDate": "2024-06-19T08:07",
    "size": 467097,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT04587050/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [],
  "studyType": "OBSERVATIONAL",
  "enrollmentInfo": {
    "enrollmentCount": 57,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2021-07-19",
    "completionDate": "2023-06-30",
    "primaryCompletionDate": "2023-06-30",
    "firstSubmitDate": "2020-10-07",
    "firstPostDate": "2020-10-14"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria - Cohort 1:\n\n* Perinatally acquired HIV aged 18+\n* Sexually active\n* Able to give informed consent\n\nInclusion Criteria - Cohort 2:\n\n* Perinatally acquired HIV aged 18+\n* Able to give informed consent\n\nExclusion Criteria - Cohort 1:\n\n* Pregnancy\n* Not sexually active\n* Previous total abdominal hysterectomy\n* Unable to give informed consent\n\nExclusion Criteria - Cohort 2:\n\n* Unable to give informed consent",
    "healthyVolunteers": false,
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Prevalence of Abnormal Cervical Cytology",
        "description": "Cervical sample taken in the clinic setting and sent to the laboratory for cytological examination. Prevalence of abnormal cytology is reported as the number of samples that had a non-normal cytology result (e.g. dyskaryotic cells) out of the total number tested",
        "timeFrame": "1 year"
      }
    ],
    "secondary": [
      {
        "measure": "Prevalence of High Risk HPV by Subtype",
        "description": "Cervical sample taken in the clinic setting and tested for high-risk HPV on site using the Cepheid GeneXpert. Prevalence reported as the number of samples that were positive for any high-risk HPV out of all those tested",
        "timeFrame": "1 year"
      },
      {
        "measure": "Prevalence of CIN2+",
        "description": "Participants with abnormal cytology and/or tested positive for high-risk HPV were referred for colposcopy. Prevalence reported as the number of participants who were diagnosed with CIN2+",
        "timeFrame": "1 year"
      },
      {
        "measure": "HPV Serology (16/18)",
        "description": "Number of participants testing positive for HPV 16 and 18 antibodies out of the those tested",
        "timeFrame": "1 year"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 3,
      "otherCount": 0,
      "totalCount": 4
    },
    "studyDesign": {
      "phases": [],
      "isRandomized": false,
      "isMasked": true
    },
    "overallComplexityScore": 44,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:30:20.109Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}